Table of Contents
Adrafinil is considered a novel pharmaceutical which contains several behaviour-activating effects . Adrafinil has to be involved with, and used for treating deficiencies in arousal or vigilance . In addition, adrafinil is known to be used for treating attention difficulties, sleep, memory and mild depression 
Figure 1: Adrafinil carries its IUPAC name: 2-benzhydrylsulfinyl-N-hydroxyacetamide. 
How Adrafinil works
As a prodrug, adrafinil is metabolised – in the body – to modafinil, which is the primary metabolite of adrafinil [3,4]. It is metabolised in the liver .
Benefits, safety & side effects of Adrafinil
Adrafinil can counter problems associated with vigilance, attention, concentration, learning, memory and depressive manifestations . Adrafinil is very similar to modafinil and Armodafinil , and increases alertness minus the addictive nature, having minimal impact on sleep structure .
Adrafinil and modafinil
Modafinil is a psychostimulant  with effects similar to adrafinil – alertness, mitigating fatigue. Modafinil’s half-life has been described as ranging from 12 – 15 hours . Modafinil may modify areas of the brain involved in regulating the sleep/wake cycle .
Prior research shows modafinil on hypersomnia and narcolepsy showed that it significantly reduced the number of drowsiness and sleep episodes during the day . Standard therapeutic dose of modafinil, in adult patients, has been described as a daily dose of between 200-400mg .
Figure 4a. The structures of both Modafinil (left) and adrafinil (right). Both psychostimulants have been suggested to be effective treatments for ADHD and opioid-induced sedation .
Adrafinil and phenibut
Phenibut, or 3-phenyl-4-aminobutyric acid, is a psychotropic drug that carries nootropic properties, and is widely used as a mood elevator and tranquilizer . Side effects from phenibut intoxication – which can occur from as little as 3g daily over 4 days, to a 30g single dose – include lethargic altered mental status, muscle ‘spasms’, described as dystonia, and, hyperthermia .
Adrafinil and Adderall
Adderall is a commonly abused prescription drug among college students , and is used for the treatment of ADHD . For this reason, Adderall has been listed as a Schedule II substance by the Drug Enforcement Administration (DEA).
Adrafinil, in memory, concentration, learning, along with depressive manifestations is dose-dependent .
Similarly, Modafinil has been reported as having a low level of toxicity: higher than 1g/kg, and around 400mg/kg in canines .
A 20mg/kg dose in Beagle dogs was shown to enhance cognition in non-human subjects .
In measuring locomotor activity in ages canines, Adrafinil at doses between 20-40mg/kg reliably increased over a month of daily treatment .
Results from animal studies looking at how long Adrafinil lasts in the ‘system’ shows a gradual decline of Adrafinil (metabolism) at around ~10-12 hours.
Regulatory and legal status
In the US, adrafinil has not been FDA approved. Adrafinil is prescribed in the treatment of narcolepsy.
In 2004, The World Anti-Doping Agency announced and implemented adrafinil to its list of substances prohibited for athletic competition . The use of Adrafinil and Modafinil are banned in sports; stipulated by the WADA from their Central Nervous System stimulating effects .